Health & Fitness
Health and Fitness
Health and Fitness
Mon, January 10, 2011
Sun, January 9, 2011
Fri, January 7, 2011
AngioDynamics to Present at the 29th Annual J.P. Morgan Healthcare Conference
ALBANY, N.Y.--([ BUSINESS WIRE ])--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the 29th Annual J.P. Morgan Healthcare Conference at 2 p.m. PT on Thursday, January 13, 2011, at the Westin St. Francis Hotel in San Francisco, Calif. Jan Keltjens, President and Chief Executive Officer of AngioDynamics, will review the Companya™s business strategy and recent corporate developments.
A live webcast of AngioDynamicsa™ presentation may be accessed through the investor relations section of the Companya™s Web site at [ http://investors.angiodynamics.com ], where an archived replay of the presentation also will be available for 90 days after the live presentation.
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. AngioDynamicsa™ diverse product lines include market-leading radiofrequency and irreversible electroporation ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at [ www.angiodynamics.com ].
